Ryan Eastman is a senior finance business partner at Doncaster & Bassetlaw NHS Foundation Trust. In his blog, Ryan discusses how the Elizabeth Garrett Anderson programme helped him to understand how his work links to the wider NHS and to high quality patient care.
Continue reading ““I believe leaders are essential in driving change in organisations, but it can’t be done alone””
Lianne Nunn is a deputy service manager at the Norfolk and Suffolk NHS Foundation Trust. Lianne completed the Elizabeth Garrett Anderson programme for mid to senior level leaders in July 2018. Lianne shared her experience of the programme and how it led to her creating new and improved patient pathways.
Continue reading ““Be ready to positively change the way you work and the way you think””
John Sheridan has worked in the NHS for 23 years, starting as an A&E receptionist. Now Macmillan Lead Nurse for End of Life Care and Operational Lead for Specialist Palliative Care, John reflects on how the Elizabeth Garrett Anderson programme has impacted on his role and his approach to leadership.
Continue reading ““Empathy and humility should be a mainstay of our daily routine, irrespective of where we lead from.””
Bob Dennes is a service manager in Theatres at Western Sussex NHS Foundation Trust and has completed both the Mary Seacole and Elizabeth Garrett Anderson programmes (EGA). In his blog, Bob reflects on the service improvements he’s made since completing the Mary Seacole programme back in 2013 and more recently, his focus on continuously improving patient services since completing the EGA programme.
Continue reading ““If you’re thinking about applying for an Academy programme, you’re already halfway there!””
Sally Scales leads the NHS Leadership Academy’s Executive Search function and graduated from the Elizabeth Garrett Anderson programme in July 2017. In the first of two blogs, Sally revisits her dissertation, during which she discovered that the barriers to reaching board level for black, Asian and minority ethnic (BAME) nurse leaders are still very much in evidence.